Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MGAT4EP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
IL1R2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
KATNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRSS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC191 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00853 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HIST1H4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF576 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KMT2D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC140 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAPN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CASQ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CYP3A4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on